|1.||Banerjee, Kaushik: 1 article (01/2014)|
|2.||Ganguly, Avishek: 1 article (01/2014)|
|3.||Choudhuri, Soumitra Kumar: 1 article (01/2014)|
|4.||Chakraborty, Paramita: 1 article (01/2014)|
|5.||Barra, Héctor S: 1 article (10/2003)|
|6.||Bisig, C Gastón: 1 article (10/2003)|
|7.||Contin, María A: 1 article (10/2003)|
|8.||Purro, Silvia A: 1 article (10/2003)|
|9.||Arce, Carlos A: 1 article (10/2003)|
10/01/2003 - "Studies by other groups have shown that treatment of certain types of cultured cancer cells with azatyrosine leads to reversion of phenotype to normal, and that administration of azatyrosine into animals harbouring human proto-oncogenic c-Ha- ras prevents tumour formation. "
01/01/1999 - "The administration of azatyrosine also inhibits tumor formation in transgenic mice harboring the normal human c-Ha-ras which is mutated during treatment with various chemical carcinogens. "
01/23/2014 - "Under this backdrop, in search of less toxic and more effective MDR reversing agents our laboratory has developed the different metal chelates of Schiff base N-(2-hydroxy acetophenone)glycinate (NG) which is structurally similar to azatyrosine [L-β-(5-hydroxy-2-pyridyl)-alanine] that inhibits tumor formation by deactivating the c-Raf-1 kinase and c-Ha-ras signalling pathway. "
|2.||Prostatic Neoplasms (Prostate Cancer)
09/01/1995 - "In this study, we investigated the effect of azatyrosine on human prostate cancer cell growth and the reversion potential of this antibiotic on prostate tumorigenic cell lines. "
09/01/1995 - "This reversion of prostate cancer cells to an apparently nontumorigenic phenotype points to a potentially significant therapeutic role for azatyrosine in the treatment of advanced prostate cancer."
09/01/1995 - "These results suggest that azatyrosine inhibits prostate tumorigenic growth; it has a high reversion efficiency on human prostate cancer cells; and the K-rev-1 suppressor gene and the bcl-2 proto-oncogene could be potentially involved in the reversion mechanism mediated by azatyrosine. "
09/01/1995 - "Incubation with azatyrosine (for 7 days) resulted in greater than 95% in vitro growth inhibition of the three parental prostate cancer cell lines. "
09/01/1995 - "Three androgen-independent human prostate cancer cell lines (TSU-Prl, DU-145, and PC-3) were cultured in the presence of azatyrosine and their growth rates were determined over a 7-day period. "
01/01/1990 - "Permanent conversion of NIH3T3 cells transformed by activated c-Ha-ras, c-Ki-ras, N-ras, or c-raf, and of human pancreatic adenocarcinoma containing activated c-Ki-ras to apparently normal cells by treatment with the antibiotic azatyrosine."
01/01/1989 - "Human pancreatic adenocarcinoma cells, which are known to contain an amplified activated c-Ki-ras gene and an amplified c-myc gene, were also converted to flat and giant revertant cells by treatment with azatyrosine."
|2.||Schiff Bases (Schiff Base)